Severe respiratory Diseases

Severe Respiratory Diseases

Severe respiratory diseases

Around 100,000 people worldwide suffer from Cystic Fibrosis, the most common severe genetic disease. This multi-organ disease mainly affects the lungs, which are hit by chronic infections and inflammations that cause their progressive deterioration. 

*Sources: ECFS Patient Registry, Report 2015

200

New cases of Cystic Fibrosis every year in Italy

Source: ECFS Patient Registry, Report 2015
48%

Cases of Cystic Fibrosis affecting children in Europe

Source: ECFS Patient Registry, Report 2015

We want to develop treatments that play a key role in treating Cystic Fibrosis, as well as in managing severe respiratory diseases

Malattie respiratorie severe

PIPELINE - Respiratory Tract

Preclinical
Phase 1
Phase 2
Phase 3
Phase 4
Preclinical
Anti Mycobacterial
Preclinical
New Antifungal
Preclinical
New Peptide
Preclinical
Antioxidant
Phase 2
CF
Phase 3
NCFBE-1
Phase 3
NCFBE-2
Phase 3
BOS

OUR DIRECT PRESENCE

contact
PARTNERNING OPPORTUNITIES
Business Development Department
+39 02 66524455